InvestorsHub Logo
Followers 9
Posts 1138
Boards Moderated 0
Alias Born 03/20/2022

Re: PennyWorld post# 33988

Monday, 12/05/2022 9:32:57 PM

Monday, December 05, 2022 9:32:57 PM

Post# of 36590
An Accurate Revive vs Relief Comparison...............



TRIALS:
Revive - Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Bucillamine in Patients With Mild-Moderate COVID-19
Relief - Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-2)


TRIAL STATUS:
Revive - Submissions before FDA for consideration (Ongoing)
Relief - EUA request Rejected


SHARE STRUCTURE:
Revive - ~350 Million
Relief - 4.4 Billion



I could go on further but the criteria cited above adequately exposes the false equivalence being made.